ask="51.50"
ask_size="100"
average_daily_volume="406966"
bid="42.59"
bid_size="100"
book_value="14.89"
change="-0.05"
change_from_200_day_moving_average="-6.33"
change_from_50_day_moving_average="-6.37"
change_from_52_week_high="-17.15"
change_From_52_week_low="15.82"
change_in_percent="-0.11%"
close="43.83"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="8.95"
ebitda="267.62M"
eps_estimate_current_year="-2.27"
eps_estimate_next_quarter="-0.74"
eps_estimate_next_year="-3.15"
ex_dividend_date="N/A"
float_shares="24015000"
high="44.14"
high_52_weeks="60.98"
last_trade_date="1/25/2017"
last_trade_price="43.83"
last_trade_size="14160"
last_trade_time="4:00pm"
low="42.28"
low_52_weeks="28.01"
market_capitalization="1.19B"
moving_average_200_day="50.16"
moving_average_50_day="50.20"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="60.17"
open="44.05"
pe_ratio="4.90"
peg_ratio="0.32"
percent_change_from_200_day_moving_average="-12.62%"
percent_change_from_50_day_moving_average="-12.70%"
percent_change_from_52_week_high="-28.12%"
percent_change_from_52_week_low="+56.48%"
previous_close="43.88"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.95"
price_per_sales="3.09"
revenue="385.77M"
shares_outstanding="27138000"
short_ratio="6.09"
stock_exchange="NMS"
symbol="FPRX"
volume="352009"
weeks_range_52="28.01 - 60.98"
